Trial · NCT00979550
The Effects of Aldara as an Adjunct to Laser Treatment
NCT00979550, Phase 2, Terminated, Henry Vasconez; results first posted 2018-03-22
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Effects of Aldara as an Adjunct to Laser Treatment. Trials, record NCT00979550. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00979550
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Effects of Aldara as an Adjunct to Laser Treatment
- NCT number
- NCT00979550
- Status
- Terminated
- Phases
- Phase 2
- Enrollment
- 7 participants, actual
- Lead sponsor
- Henry Vasconez
- Conditions
- Port Wine Stains
- Interventions
- Imiquimod, non-medicated petroleum cream
- First posted
- 2009-09-18
- Last updated
- 2018-03-22
- Results first posted
- 2018-03-22
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Effects of Aldera Cream on the Reduction of Port Wine Stain (Vascular Malformation) | 3 months | Lesions will be digitally photographed and its surface area measured by blinded observers using image analysis software |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Effects of Aldera Cream on the Reduction of Port Wine Stain (Vascular Malformation) | 3 months |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Aldara Cream | 4 | |
| Overall Study | STARTED | Non-medicated Petroleum Cream | 3 | |
| Overall Study | COMPLETED | Aldara Cream | 4 | |
| Overall Study | COMPLETED | Non-medicated Petroleum Cream | 3 | |
| Overall Study | NOT COMPLETED | Aldara Cream | 0 | |
| Overall Study | NOT COMPLETED | Non-medicated Petroleum Cream | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Aldara Cream | 0 | 4 |
| Total, all-cause mortality | Non-medicated Petroleum Cream | 0 | 3 |
| Total, other adverse events | Aldara Cream | 0 | 4 |
| Total, other adverse events | Non-medicated Petroleum Cream | 0 | 3 |
| Total, serious adverse events | Aldara Cream | 0 | 4 |
| Total, serious adverse events | Non-medicated Petroleum Cream | 0 | 3 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Aldara Cream vs Non-medicated Petroleum Cream: deaths from any cause | Trial comparisons |
| Aldara Cream vs Non-medicated Petroleum Cream: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00979550
GET https://conductscience.org/api/trials/v1/NCT00979550/registered